Tangeretin, a citrus polymethoxyflavonoid, induces apoptosis of human gastric cancer AGS cells through extrinsic and intrinsic signaling pathways

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1788-1794

  Dong, Yang ^a   Cao, Aili ^a   Shi, Jianrong ^a   Yin, Peihao ^a   Wang, Li ^a   Ji, Guang ^a   Xie, Jianqun ^a   Wu, Dazheng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Gastric cancer; Mitochondria; Tangeretin

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 1; FAS ANTIGEN; FAS LIGAND; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BID; PROTEIN P21; PROTEIN P53; TANGERETIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN AGS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; FLAVONES; FLOW CYTOMETRY; HUMANS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84908145653     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3034     Document Type: Article

References (32)

1. Wang D, Wang J, Huang X, Tu Y and Ni K: Identification of polymethoxylated flavones from green tangerine peel (Pericarpium Citri Reticulatae Viride) by chromatographic and spectroscopic techniques. J Pharm Biomed Anal 44: 63-69, 2007.
2. Hirano T, Abe K, Gotoh M and Oka K: Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 72: 1380-1388, 1995.
3. Rooprai HK, Kandanearatchi A, Maidment SL, et al: Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol Appl Neurobiol 27: 29-39, 2001.
4. Martinez Conesa C, Vicente Ortega V, Yanez Gascon MJ, et al: Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. J Agric Food Chem 53: 6791-6797, 2005.
5. Manthey JA and Guthrie N: Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 50: 5837-5843, 2002.
6. Ishii K, Tanaka S, Kagami K, et al: Effects of naturally occurring polymethyoxyflavonoids on cell growth, P-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. Cancer Invest 28: 220-229, 2010.
7. Morley KL, Ferguson PJ and Koropatnick J: Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 251: 168-178, 2007.
8. Pan MH, Chen WJ, Lin-Shiau SY, Ho CT and Lin JK: Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23: 1677-1684, 2002.
9. Chen KH, Weng MS and Lin JK: Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem Pharmacol 73: 215-227, 2007.
10. Lust S, Vanhoecke B, Van Gele M, Philippe J, Bracke M and Offner F: The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562. Mol Nutr Food Res 54: 823-832, 2010.
11. Arafa el SA, Zhu Q, Barakat BM, et al: Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res 69: 8910-8917, 2009.
12. Gao J, Senthil M, Ren B, et al: IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells. Cell Death Differ 17: 699-709, 2010.
13. Jiang XH, Wong BC, Lin MC, et al: Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells. Oncogene 20: 8009-8018, 2001.
14. Linke SP, Clarkin KC and Wahl GM: p53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation. Cancer Res 57: 1171-1179, 1997.
15. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP and Hall PA: Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 108: 1843-1848, 1995.
16. Goldstein I, Marcel V, Olivier M, Oren M, Rotter V and Hainaut P: Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Ther 18: 2-11, 2011.
17. Dong Y, Ji G, Shi JR, Cao AL, Xie JQ and Wu DZ: Arrest of human gastric cancer AGS cells by tangeretin via cyclin B1 upregulation and inhibition of ERK phosphorylation. Chin Pharmacol Bull 28: 5, 2012.
18. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
19. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999.
20. Dias N and Bailly C: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70: 1-12, 2005.
21. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME: Apoptosis signaling by death receptors. Eur J Biochem 254: 439-459, 1998.
22. Rao RV, Ellerby HM and Bredesen DE: Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 11: 372-380, 2004.
23. Zamzami N, Marchetti P, Castedo M, et al: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182: 367-377, 1995.
24. Zamzami N, Marchetti P, Castedo M, et al: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181: 1661-1672, 1995.
25. Kudla G, Montessuit S, Eskes R, et al: The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved bid is inhibited by the N-terminal fragment. J Biol Chem 275: 22713-22718, 2000.
26. Roucou X, Montessuit S, Antonsson B and Martinou JC: Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J 368: 915-921, 2002.
27. Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM and Gottlieb E: BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ 18: 538-548, 2011.
28. Vousden KH and Lu X: Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604, 2002.
29. Cui Q, Yu JH, Wu JN, et al: P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 28: 1057-1066, 2007.
30. Lu L, Dong Y, Shi JR and Wu DZ: Tangeretin enhances the proliferation inhibition of 5-fluorouracil in human gastric cancer AGS cells. Chin Pharmacol Bull 27: 760-763, 2011.
31. Bunz F, Dutriaux A, Lengauer C, et al: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998.
32. Kurland JF and Meyn RE: Protease inhibitors restore radiation-induced apoptosis to Bcl-2-expressing lymphoma cells. Int J Cancer 96: 327-333, 2001.